Commercialisation of Tyrian’s ReadRite® Test Kicks Off in Canada

Tyrian Diagnostics Limited (ASX:TDX) announced today that the company has completed the manufacture of an initial order of commercial ReadRite® alpha-amylase kits for Bayer CropScience AG, intended to be rolled-out in the North American market. The ReadRite test, which detects alpha-amylase in wheat, performed very well in an independent official evaluation which confirmed the test as a reliable measure for the determination of wheat quality.

This test, formerly referred to as WheatRite, is being marketed in Canada as the ReadRite alpha-amylase test for use with Tyrian’s Reader. The test provides grain industry stakeholders with a rapid, easy to use, and quantitative method for determining the quality of wheat at Point of Need.

“The results of the evaluation and the launch of the ReadRite product is a major accomplishment for Tyrian, and validates our DiagnostIQ™ platform in the agriculture industry,” said Jenny Harry, PhD, Chief Executive Officer of Tyrian Diagnostics. “We have developed a strong working relationship with Bayer CropScience, and we look forward to continued collaboration on this and future products.”

Tyrian will continue to manufacture ReadRite® test kits in house, whilst concurrently establishing outsourced manufacturing of the kits to meet forecast sales increases in North America and other regions.

About ReadRite alpha-amylase test

The ReadRite® alpha-amylase test is a rapid wheat quality test that can be completed in five minutes and enables growers to make an on-farm assessment of the extent of rain damage to a crop in order to separate sound grain from damaged grain. The test is available as a rapid visual test that can be interpreted without instrumentation, or used in conjunction with the ReadRite® Reader to provide a more definitive quantitative result. Rain damage has a significant impact on the pricing of harvested wheat. Grading must be conducted by trading authorities prior to sale and/or export, but also may be performed at multiple points in the chain, from on-farm to wheat processor, to monitor and confirm grain quality.

About Tyrian’s DiagnostIQ Reader

Tyrian’s DiagnostIQ Reader is a proprietary device that utilizes optical detection technology combined with customized software to provide a quantitative measure of the level of diagnostic targets in samples processed in Tyrian’s point of need DiagnostIQ tests. The Reader can be configured to detect diagnostic targets in a wide range of sample types, and therefore has utility in the healthcare, agricultural, and veterinary fields.

About Tyrian Diagnostics

Tyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise in biomarker discovery and validation and diagnostic test development with a core focus on respiratory and infectious diseases. Tyrian’s product pipeline includes:

• ReadRite® tests for crop quality management, which are partnered with Bayer CropScience; and
• a rapid test for active tuberculosis, in collaboration with the US-based group Becton, Dickinson and Company.

In addition, Tyrian has many partnering opportunities in alternative fields, given its capabilities to work across the entire spectrum of diagnostic test development – from identification and isolation of biomarkers, point-of-need test design, clinical development or field testing to final product. Core technology of the company includes the DiagnostIQ test format, a handheld device that allows rapid and easy detection of protein markers associated with particular medical, veterinary or agricultural conditions.

Additional information about Tyrian Diagnostics can be found at www.tyriandx.com